Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 13, 2017 – The FDA announced the approval of Ifixi (infliximab-qbtx), Pfizer’s biosimilar to Janssen Biotech’s Remicade® (infliximab).
Download PDF
Return to publications
